Showing results (91-100 of 2,507) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2019
Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple MyelomaHélène Caillon, Hervé Avet-Loiseau, Michel Attal, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 17, 2019
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III TrialGuillermo Garcia-Manero, Antonio Almeida, Pierre Fenaux, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival EndpointAaron S Rosenberg, Thierry Facon, Kejal Parikh, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 14, 2021
Overweight/Obesity and Monoclonal Gammopathy of Undetermined SignificanceRebecca Georgakopoulou, Angeliki Andrikopoulou, Theodoros N Sergentanis, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2021
Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCLShoko Marshall, Noriko Nishimura, Norihito Inoue, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2021
Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell LymphomaBrian G Bazzell, Lydia L Benitez, Bernard L Marini, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2021
Trends in Early Mortality From Multiple Myeloma: A Population-Based AnalysisVivek Kumar, Meghna Ailawadhi, Navnita Dutta, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 25, 2021
Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO CriteriaAndrew Fairchild, Chad M McCall, Taofik Oyekunle, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 21, 2021
Advances in Frontline Management of Peripheral T-cell LymphomaChathuri Abeyakoon, Carrie van der Weyden, Sean Harrop, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 8, 2021
Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib TherapyLucia Masarova, Prithviraj Bose, Naveen Pemmaraju, et al.
Pageof 251